Skip to content

Author

M. Maruyama

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Stepwise intensification of guideline-directed medical therapy is associated with reduced major adverse kidney events in patients with HFpEF and diabetes

Diabetes mellitus is the leading cause of chronic kidney disease and is strongly associated with cardiovascular and all-cause mortality. Heart failure with preserved ejection fraction (HFpEF) frequently coexists with diabetes and confers high cardiorenal risk. Contemporary management of diabetic kidney disease is...

Y. Hoshika, Y. Kubota, T. Nishino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.